MedPath

Treatment Strategy in Patients With High-risk of Postextubation Distress in ICU Based on a Lung Ultrasound Score Versus Standard Strategy

Phase 3
Completed
Conditions
Adult Patients Ventilated More Than 48 h
Interventions
Device: lung ultrasound score
Registration Number
NCT02123940
Lead Sponsor
University Hospital, Clermont-Ferrand
Brief Summary

Prospective, randomized clinical multicentric study in ICU during weaning from mechanical ventilation.

Detailed Description

Prospective randomized clinical multicentric study on ICU comparing a treatment strategy (nasal humidified high flow therapy and Noninvasive Ventilation) in patients with high-risk of postextubation distress in ICU based on a Lung Ultrasound Score VERSUS standard strategy

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
483
Inclusion Criteria
  • Adult patients ventilated more than 48 h
  • Stable respiratory and hemodynamic conditions for SBT
  • Consent of patients
  • Arterial line
Exclusion Criteria
  • severe COBP
  • Laryngeal dyspnea
  • Tracheostomy
  • Arrhythmia
  • No echogenicity
  • Paraplegia >T8

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
nasal humidified high flow therapylung ultrasound scoreProspective randomized clinical multicentric study on ICU comparing a treatment strategy (nasal humidified high flow therapy and Noninvasive Ventilation) in patients with high-risk of postextubation distress in ICU based on a Lung Ultrasound Score VERSUS standard strategy
standard strategylung ultrasound scoreProspective randomized clinical multicentric study on ICU comparing a treatment strategy (nasal humidified high flow therapy and Noninvasive Ventilation) in patients with high-risk of postextubation distress in ICU based on a Lung Ultrasound Score VERSUS standard strategy
Primary Outcome Measures
NameTimeMethod
Incidence of postextubation distressduring 48 hour (at day 1)

postextubation period requiring a ventilatory support (reintubation or curative Noninvasive ventilation).

Secondary Outcome Measures
NameTimeMethod
Number of ventilator-free-daysat day 1 (after extubation)
Length of stay in ICUat day 1
Mortality in ICUat day 1
Extubation failureat day 7

Extubation failure within the 7 days following planned extubation

Trial Locations

Locations (1)

CHU de Clermont-Ferrand

🇫🇷

Clermont-Ferrand, France

© Copyright 2025. All Rights Reserved by MedPath